The largest database of trusted experimental protocols

3 protocols using mjf r21

1

Antibody Profiling of LRRK2 Modifications

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies used include: mouse monoclonal anti-GFP (clones 7.1 and 13.1, Sigma), mouse monoclonal anti-LRRK2 (clone N241A/34, NeuroMabs), rabbit monoclonal anti-LRRK2 (clone MJFF2/c41-2, Abcam), mouse monoclonal anti-FLAG and anti-FLAG-HRP (clone M2, Sigma), rabbit monoclonal anti-pSer910-LRRK2 [clone UDD1 15 (3 (link)), Abcam], rabbit monoclonal anti-pSer935-LRRK2 [clone UDD2 10 (12 (link)), Abcam], rabbit monoclonal anti-pSer1292-LRRK2 (clone MJFR-19-7-8, Abcam), mouse monoclonal anti-β-tubulin (TUB 2.1, Sigma), rabbit polyclonal anti-dynamin-1 (PA1-660, Thermo Fisher Scientific), rabbit polyclonal anti-tyrosine hydroxylase (NB300-109, Novus Biologicals), rabbit monoclonal anti-phospho-Thr73-RAB10 (MJF-R21 or MJF-R21-22–5, Abcam), anti-phospho-Thr72-RAB8A (MJF-R20, Abcam), rabbit monoclonal anti-RAB10 (D36C4, Cell Signaling Technology), mouse monoclonal anti-human adenovirus 5, hexon capsid protein (clone 9C12, Developmental Studies Hybridoma Bank), mouse monoclonal anti-GAPDH (clone 1E6D9, Protein Tech). For bright-field microscopy, biotinylated goat anti-mouse and anti-rabbit secondary antibodies (Vector Laboratories) were employed. For Western blots, light chain-specific mouse anti-rabbit IgG-HRP and goat anti-mouse IgG-HRP (Jackson Immunoresearch) secondary antibodies were used.
+ Open protocol
+ Expand
2

LRRK2 and Rab10 Phosphorylation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein lysates were electrophoresed on a 7.5% Mini-Protean TGX stain- free gel (BioRad) and then transferred onto Immobilon-FL membranes (Millipore) and blocked with Odyssey Blocking Buffer (LiCOR). Membranes were cut in half below the high-molecular weight markers. Primary antibodies included mouse anti-LRRK2 clone N241A/34 (1: 2000, Antibodies, Inc.), rabbit anti-LRRK2 antibody MJFF2 (1:2000, Abcam), Ser(P)-935 (1: 2000, Abcam), Ser(P)-1292 (1:2000, Abcam) HSPA8 (1:5000, Cell Signaling), phospho-T73-Rab10 antibody (1:1000, MJF-R21, Abcam), and total Rab10 (1:1000, clone D36C4, Cell Signaling). Secondary antibodies were IRdye 680LT donkey anti-mouse and IRdye 800CW donkey anti-rabbit (both 1:10000, LiCOR). Membranes were scanned using a LiCOR CLx with 685-nm and 785-nm lasers and band intensities were quantified using the LiCOR-Odyssey system.
+ Open protocol
+ Expand
3

Antibodies and Mouse Model for LRRK2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies for LRRK2 [MJFF2 (C41-2)] (# ab133474), phospho-S935-LRRK2 [UDD2 10 ( 12)] (#ab133450), phospho-T73-Rab10 [MJF-R21] (# ab230261), Rab10 [MJF-R23] (# ab237703), and RPL10a (# ab55544) were from Abcam. Anti-tyrosine hydroxylase was from Millipore (#AB1542). Antibodies for eIF2B5(sc-28854), eIF2α (sc-11386), phospho-eIF2α-S52 (sc-101670), eIF4G3 (sc-100732), and Ndufs3 (sc-292169) were from Santa Cruz Biotechnology. Anti-Rab8 (#R66320) and Rab4 (#R68520) were from BD Transduction Laboratories. Anti-4E-BP1 (# 9452), eEF2 (#2332) and phospho-eEF2(T57) (#2331) were from Cell Signaling Technology and anti-actin (# A3853) was from Sigma-Aldrich. LRRK2-IN1 was from Merck Millipore (# 438193), GSK-2578215A (#4629) and MLi-2 (# 5756) were from Tocris Bioscience. Miglyol 812N was from Cemer Oleo, GmbH, and Co, KG (Germany). Patient cells were from the National Institute of Neurological Disorders and Stroke (NINDS) repository at the Coriell Institute for Medical Research and the Cell Line and DNA Biobank from Patients Affected by Genetic Diseases, Telethon Network of Genetic Biobanks (TNGB) (project no. GTB12001). 23 C57BL/6-Lrrk2 tm1.1Mjff /J mice developed by Michael J. Fox Foundation 24 were obtained from The Jackson Laboratory (Stock no. 016121).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!